BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Fishbane S, Galgano C, Langley RC Jr, Canfield W, Maesaka JK. Reticulocyte hemoglobin content in the evaluation of iron status of hemodialysis patients. Kidney Int 1997;52:217-22. [PMID: 9211366 DOI: 10.1038/ki.1997.323] [Cited by in Crossref: 150] [Cited by in F6Publishing: 116] [Article Influence: 6.0] [Reference Citation Analysis]
Number Citing Articles
1 Arndt U, Kaltwasser JP, Gottschalk R, Hoelzer D, Möller B. Correction of iron-deficient erythropoiesis in the treatment of anemia of chronic disease with recombinant human erythropoietin. Ann Hematol 2005;84:159-66. [PMID: 15565327 DOI: 10.1007/s00277-004-0950-z] [Cited by in Crossref: 32] [Cited by in F6Publishing: 20] [Article Influence: 1.8] [Reference Citation Analysis]
2 Schaefer RM, Schaefer L. Hypochromic red blood cells and reticulocytes. Kidney International 1999;55:S44-8. [DOI: 10.1046/j.1523-1755.1999.055suppl.69044.x] [Cited by in Crossref: 38] [Cited by in F6Publishing: 1] [Article Influence: 1.7] [Reference Citation Analysis]
3 Rovó A, Stüssi G, Meyer-Monard S, Favre G, Tsakiris D, Heim D, Halter J, Arber C, Passweg J, Gratwohl A, Tichelli A. Sideroblastic changes of the bone marrow can be predicted by the erythrogram of peripheral blood. Int J Lab Hematol 2010;32:329-35. [PMID: 19706066 DOI: 10.1111/j.1751-553X.2009.01185.x] [Cited by in Crossref: 3] [Article Influence: 0.2] [Reference Citation Analysis]
4 Roger S; Caring for Australasians with Renal Impairment (CARI). The CARI guidelines. Haematological targets. Iron. Nephrology (Carlton) 2006;11 Suppl 1:S217-29. [PMID: 16900610 DOI: 10.1111/j.1440-1797.2006.00647.x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
5 Mitsopoulos E, Tsiatsiou M, Zanos S, Katodritou E, Visvardis G, Papadopoulou D, Passadakis P, Vargemezis V, Tsakiris D. Impact of C-reactive protein on absolute reticulocyte count in haemodialysis patients: the role of iron status. Nephrology Dialysis Transplantation 2011;26:992-7. [DOI: 10.1093/ndt/gfq470] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
6 Kirschbaum B. Hypotransferrinemia of chronically hemodialyzed patients. Artif Organs 1999;23:1047-54. [PMID: 10619922 DOI: 10.1046/j.1525-1594.1999.06328.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.3] [Reference Citation Analysis]
7 Riley RS, Ben-ezra JM, Tidwell A, Romagnoli G. Reticulocyte analysis by flow cytometry and other techniques. Hematology/Oncology Clinics of North America 2002;16:373-420. [DOI: 10.1016/s0889-8588(02)00005-9] [Cited by in Crossref: 29] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
8 Balla J, Jeney V, Varga Z, Komódi E, Nagy E, Balla G. Iron homeostasis in chronic inflammation. Acta Physiologica Hungarica 2007;94:95-106. [DOI: 10.1556/aphysiol.94.2007.1-2.9] [Cited by in Crossref: 19] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
9 Besarab A, Drueke TB. The problem with transferrin saturation as an indicator of iron 'sufficiency' in chronic kidney disease. Nephrol Dial Transplant 2021;36:1377-83. [PMID: 32301986 DOI: 10.1093/ndt/gfaa048] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
10 Ogawa C, Tsuchiya K, Tomosugi N, Shimada K, Kanda F, Maeda K. The target hemoglobin content values of reticulocytes for efficient anemia improvement are achieved by low ferritin levels and moderate transferrin saturation: a retrospective observational study. Hematology 2020;25:71-8. [PMID: 32009585 DOI: 10.1080/16078454.2020.1720103] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Mikhail A, Brown C, Williams JA, Mathrani V, Shrivastava R, Evans J, Isaac H, Bhandari S. Renal association clinical practice guideline on Anaemia of Chronic Kidney Disease. BMC Nephrol 2017;18:345. [PMID: 29191165 DOI: 10.1186/s12882-017-0688-1] [Cited by in Crossref: 80] [Cited by in F6Publishing: 59] [Article Influence: 16.0] [Reference Citation Analysis]
12 Richardson D, Bartlett C, Will EJ. Optimizing erythropoietin therapy in hemodialysis patients. American Journal of Kidney Diseases 2001;38:109-17. [DOI: 10.1053/ajkd.2001.25203] [Cited by in Crossref: 42] [Cited by in F6Publishing: 28] [Article Influence: 2.0] [Reference Citation Analysis]
13 Mittal S, Maesaka JK, Fishbane S. Diagnosis of Iron Deficiency in End‐Stage Renal Disease. Seminars in Dialysis 2002;12:231-4. [DOI: 10.1046/j.1525-139x.1999.99026.x] [Cited by in Crossref: 3] [Article Influence: 0.2] [Reference Citation Analysis]
14 Bakr AF, Sarette G. Measurement of reticulocyte hemoglobin content to diagnose iron deficiency in Saudi children. Eur J Pediatr 2006;165:442-5. [DOI: 10.1007/s00431-006-0097-0] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
15 Kawai Y, Toya Y, Wakui H, Fujikawa T, Ueda E, Azushima K, Kinguchi S, Mitsuhashi H, Kawano T, Kuji T, Yamaguchi S, Ohnishi T, Tamura K. Potential effective treatment of shortening continuous erythropoietin receptor activator treatment interval combined with iron supplementation in hemodialysis patients. J Pharmacol Sci 2021;147:118-25. [PMID: 34294362 DOI: 10.1016/j.jphs.2021.05.010] [Reference Citation Analysis]
16 Briggs C. Quality counts: new parameters in blood cell counting. Int J Lab Hematol 2009;31:277-97. [PMID: 19452619 DOI: 10.1111/j.1751-553x.2009.01160.x] [Cited by in Crossref: 127] [Cited by in F6Publishing: 34] [Article Influence: 9.8] [Reference Citation Analysis]
17 Arif HM, Qian ZM, Wang R. Signaling integration of hydrogen sulfide and iron on cellular functions. Antioxid Redox Signal 2021. [PMID: 34498949 DOI: 10.1089/ars.2021.0203] [Reference Citation Analysis]
18 Mittman N. Iron replacement in rHuEPO-treated dialysis patients: DOQI and beyond. Am J Kidney Dis 1999;34:173-6. [PMID: 10401035 DOI: 10.1016/s0272-6386(99)70127-7] [Cited by in Crossref: 10] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
19 López-Ruzafa E, Vázquez-López MA, Lendinez-Molinos F, Poveda-González J, Galera-Martínez R, Bonillo-Perales A, Martín-González M. Reference Values of Reticulocyte Hemoglobin Content and Their Relation With Other Indicators of Iron Status in Healthy Children. J Pediatr Hematol Oncol 2016;38:e207-12. [PMID: 27403769 DOI: 10.1097/MPH.0000000000000639] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 1.2] [Reference Citation Analysis]
20 Powell DJ, Achebe MO. Anemia for the Primary Care Physician. Prim Care 2016;43:527-42. [PMID: 27866575 DOI: 10.1016/j.pop.2016.07.006] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 2.6] [Reference Citation Analysis]
21 Speeckaert MM, Speeckaert R, Delanghe JR. Biological and clinical aspects of soluble transferrin receptor. Critical Reviews in Clinical Laboratory Sciences 2011;47:213-28. [DOI: 10.3109/10408363.2010.550461] [Cited by in Crossref: 57] [Cited by in F6Publishing: 55] [Article Influence: 5.2] [Reference Citation Analysis]
22 Nicholas JCB. A Study of the Response of Elderly Patients with End-Stage Renal Disease to Epoetin Alfa or Beta: . Drugs & Aging 2004;21:187-201. [DOI: 10.2165/00002512-200421030-00004] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
23 Worwood M. Estimation of Body Iron Stores. In: Anderson GJ, Mclaren GD, editors. Iron Physiology and Pathophysiology in Humans. Totowa: Humana Press; 2012. pp. 499-528. [DOI: 10.1007/978-1-60327-485-2_25] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
24 Gondouin B, Hutchison CA. High Cut-off Dialysis Membranes: Current Uses and Future Potential. Advances in Chronic Kidney Disease 2011;18:180-7. [DOI: 10.1053/j.ackd.2011.02.006] [Cited by in Crossref: 41] [Cited by in F6Publishing: 37] [Article Influence: 3.7] [Reference Citation Analysis]
25 Stauder R, Valent P, Theurl I. Anemia at older age: etiologies, clinical implications, and management. Blood 2018;131:505-14. [DOI: 10.1182/blood-2017-07-746446] [Cited by in Crossref: 104] [Cited by in F6Publishing: 87] [Article Influence: 26.0] [Reference Citation Analysis]
26 Hatamizadeh P, Ravel V, Lukowsky LR, Molnar MZ, Moradi H, Harley K, Pahl M, Kovesdy CP, Kalantar-Zadeh K. Iron indices and survival in maintenance hemodialysis patients with and without polycystic kidney disease. Nephrol Dial Transplant 2013;28:2889-98. [PMID: 24169614 DOI: 10.1093/ndt/gft411] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
27 Dignass A, Farrag K, Stein J. Limitations of Serum Ferritin in Diagnosing Iron Deficiency in Inflammatory Conditions. Int J Chronic Dis 2018;2018:9394060. [PMID: 29744352 DOI: 10.1155/2018/9394060] [Cited by in Crossref: 35] [Cited by in F6Publishing: 45] [Article Influence: 8.8] [Reference Citation Analysis]
28 Kawai Y, Toya Y, Wakui H, Fujikawa T, Ueda E, Azushima K, Mitsuhashi H, Kawano T, Kuji T, Yamaguchi S, Ohnishi T, Tamura K. Comparison of the effects of weekly and biweekly intravenous CERA administration on erythropoiesis: A randomized controlled trial. J Clin Hypertens 2021;23:870-8. [DOI: 10.1111/jch.14171] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
29 Besarab A. Evaluating iron sufficiency: A clearer view. Kidney International 2001;60:2412-4. [DOI: 10.1046/j.1523-1755.2001.00078.x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 0.7] [Reference Citation Analysis]
30 Kaufman JS, Reda DJ, Fye CL, Goldfarb DS, Henderson WG, Kleinman JG, Vaamonde CA. Diagnostic value of iron indices in hemodialysis patients receiving epoetin. Kidney International 2001;60:300-8. [DOI: 10.1046/j.1523-1755.2001.00800.x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 0.8] [Reference Citation Analysis]
31 van Zyl-smit R. Diagnosis and management of iron deficiency in chronic dialysis patients: . Current Opinion in Nephrology and Hypertension 2000;9:669-74. [DOI: 10.1097/00041552-200011000-00013] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
32 D'onofrio G, Zini G, Brugnara C. Clinical Applications of Automated Reticulocyte Indices. Hematology 2016;3:165-76. [DOI: 10.1080/10245332.1998.11746388] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
33 Brugnara C. A Hematologic “Gold Standard” for Iron-deficient States?1. Clinical Chemistry 2002;48:981-2. [DOI: 10.1093/clinchem/48.7.981] [Cited by in Crossref: 23] [Cited by in F6Publishing: 14] [Article Influence: 1.2] [Reference Citation Analysis]
34 Fishbane S, Kalantar-zadeh K, Nissenson AR. Serum Ferritin in Chronic Kidney Disease: Reconsidering the Upper Limit for Iron Treatment: Serum Ferritin in CKD. Seminars in Dialysis 2004;17:336-41. [DOI: 10.1111/j.0894-0959.2004.17359.x] [Cited by in Crossref: 37] [Cited by in F6Publishing: 31] [Article Influence: 2.1] [Reference Citation Analysis]
35 Archer NM, Brugnara C. Diagnosis of iron-deficient states. Critical Reviews in Clinical Laboratory Sciences 2015;52:256-72. [DOI: 10.3109/10408363.2015.1038744] [Cited by in Crossref: 37] [Cited by in F6Publishing: 32] [Article Influence: 5.3] [Reference Citation Analysis]
36 Mitsopoulos E, Zanos S, Ginikopoulou E, Tsiatsiou M, Giannakou A, Pavlitou A, Sakellariou G. Do Serum and Red Blood Cell Folate Levels Indicate Iron Response in Hemodialysis Patients?: . ASAIO Journal 2006;52:163-8. [DOI: 10.1097/01.mat.0000199897.26150.db] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
37 Riley RS, Ben-Ezra JM, Goel R, Tidwell A. Reticulocytes and reticulocyte enumeration. J Clin Lab Anal 2001;15:267-94. [PMID: 11574956 DOI: 10.1002/jcla.1039] [Cited by in Crossref: 49] [Cited by in F6Publishing: 43] [Article Influence: 2.3] [Reference Citation Analysis]
38 Brugnara C, Schiller B, Moran J. Reticulocyte hemoglobin equivalent (Ret He) and assessment of iron-deficient states. Clin Lab Haematol 2006;28:303-8. [PMID: 16999719 DOI: 10.1111/j.1365-2257.2006.00812.x] [Cited by in Crossref: 140] [Cited by in F6Publishing: 120] [Article Influence: 8.8] [Reference Citation Analysis]
39 Domrongkitchaiporn S, Jirakranont B, Atamasrikul K, Ungkanont A, Bunyaratvej A. Indices of iron status in continuous ambulatory peritoneal dialysis patients. American Journal of Kidney Diseases 1999;34:29-35. [DOI: 10.1016/s0272-6386(99)70104-6] [Cited by in Crossref: 26] [Cited by in F6Publishing: 1] [Article Influence: 1.1] [Reference Citation Analysis]
40 Lehner J, Greve B, Cassens U. Automation in Hematology. Transfus Med Hemother 2007;34:328-39. [DOI: 10.1159/000107368] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
41 Urrechaga E, Borque L, Escanero JF. Erythrocyte and reticulocyte indices in the assessment of erythropoiesis activity and iron availability. Int Jnl Lab Hem 2013;35:144-9. [DOI: 10.1111/ijlh.12013] [Cited by in Crossref: 34] [Cited by in F6Publishing: 32] [Article Influence: 3.4] [Reference Citation Analysis]
42 Tessitore N, Solero GP, Lippi G, Bassi A, Faccini GB, Bedogna V, Gammaro L, Brocco G, Restivo G, Bernich P, Lupo A, Maschio G. The role of iron status markers in predicting response to intravenous iron in haemodialysis patients on maintenance erythropoietin. Nephrology Dialysis Transplantation 2001;16:1416-23. [DOI: 10.1093/ndt/16.7.1416] [Cited by in Crossref: 156] [Cited by in F6Publishing: 117] [Article Influence: 7.4] [Reference Citation Analysis]
43 McDonald SP, Marshall MR, Kerr PG, Russ GR. Erythropoietic agents, iron and hemoglobin--What happens beyond the trial setting: observational data from the ANZDATA registry. Hemodial Int 2004;8:257-64. [PMID: 19379425 DOI: 10.1111/j.1492-7535.2004.01103.x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
44 Karagülle M, Gündüz E, Sahin Mutlu F, Olga Akay M. Clinical significance of reticulocyte hemoglobin content in the diagnosis of iron deficiency anemia. Turk J Haematol 2013;30:153-6. [PMID: 24385778 DOI: 10.4274/Tjh.2012.0107] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
45 de Mast Q, van Dongen-Lases EC, Swinkels DW, Nieman AE, Roestenberg M, Druilhe P, Arens TA, Luty AJ, Hermsen CC, Sauerwein RW, van der Ven AJ. Mild increases in serum hepcidin and interleukin-6 concentrations impair iron incorporation in haemoglobin during an experimental human malaria infection. Br J Haematol 2009;145:657-64. [PMID: 19344417 DOI: 10.1111/j.1365-2141.2009.07664.x] [Cited by in Crossref: 46] [Cited by in F6Publishing: 47] [Article Influence: 3.5] [Reference Citation Analysis]
46 Zupan IP, Sabovic M, Salobir B, Ponikvar JB, Cernelc P, Lavre J, Vujkovac B. Association between platelet-related hemostasis impairment and functional iron deficiency in hemodialysis patients. Ther Apher Dial 2011;15:34-9. [PMID: 21272250 DOI: 10.1111/j.1744-9987.2010.00853.x] [Cited by in Crossref: 4] [Article Influence: 0.4] [Reference Citation Analysis]
47 Besarab A, Amin N, Ahsan M, Vogel SE, Zazuwa G, Frinak S, Zazra JJ, Anandan JV, Gupta A. Optimization of epoetin therapy with intravenous iron therapy in hemodialysis patients. J Am Soc Nephrol 2000;11:530-8. [PMID: 10703677 DOI: 10.1681/ASN.V113530] [Cited by in Crossref: 71] [Cited by in F6Publishing: 46] [Article Influence: 3.2] [Reference Citation Analysis]
48 Silverstein SB, Gilreath JA, Rodgers GM. Intravenous Iron Therapy: A Summary of Treatment Options and Review of Guidelines. Journal of Pharmacy Practice 2008;21:431-43. [DOI: 10.1177/0897190008318916] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
49 Crepaldi C, Brendolan A, Bordoni V, Carta MR, D'Intini V, Gastaldon F, Inguaggiato P, Ronco C. Iron management in hemodialysis patients: optimizing outcomes in Vicenza, Italy. Hemodial Int 2003;7:216-21. [PMID: 19379368 DOI: 10.1046/j.1492-7535.2003.00040.x] [Reference Citation Analysis]
50 Peerschke EI, Pessin MS, Maslak P. Using the hemoglobin content of reticulocytes (RET-He) to evaluate anemia in patients with cancer. Am J Clin Pathol 2014;142:506-12. [PMID: 25239418 DOI: 10.1309/AJCPCVZ5B0BOYJGN] [Cited by in Crossref: 12] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
51 Kwack C, Balakrishnan VS. Managing erythropoietin hyporesponsiveness. Semin Dial 2006;19:146-51. [PMID: 16551293 DOI: 10.1111/j.1525-139X.2006.00141.x] [Cited by in Crossref: 38] [Cited by in F6Publishing: 17] [Article Influence: 2.4] [Reference Citation Analysis]
52 Urrechaga E. Clinical utility of the new Beckman-Coulter parameter red blood cell size factor in the study of erithropoiesis. Int J Lab Hematol 2009;31:623-9. [PMID: 18771498 DOI: 10.1111/j.1751-553X.2008.01088.x] [Cited by in Crossref: 28] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
53 Tsuchiya K, Saito M, Okano-sugiyama H, Nihei H, Ando M, Teramura M, Iwamoto Y, Shimada K, Akiba T. Monitoring the Content of Reticulocyte Hemoglobin (CHr) as the Progression of Anemia in Nondialysis Chronic Renal Failure (CRF) Patients. Renal Failure 2009;27:59-65. [DOI: 10.1081/jdi-42792] [Cited by in Crossref: 4] [Article Influence: 0.3] [Reference Citation Analysis]
54 Spezia J, Carvalho LFDS, Camargo-Filho MFA, Furman AE, Utiyama SRDR, Henneberg R. Prevalence of anemia in schools of the metropolitan region of Curitiba, Brazil. Hematol Transfus Cell Ther 2018;40:151-5. [PMID: 30057988 DOI: 10.1016/j.htct.2017.11.007] [Reference Citation Analysis]
55 Mast AE, Blinder MA, Lu Q, Flax S, Dietzen DJ. Clinical utility of the reticulocyte hemoglobin content in the diagnosis of iron deficiency. Blood 2002;99:1489-91. [DOI: 10.1182/blood.v99.4.1489] [Cited by in Crossref: 142] [Cited by in F6Publishing: 30] [Article Influence: 7.1] [Reference Citation Analysis]
56 Piva E, Brugnara C, Spolaore F, Plebani M. Clinical Utility of Reticulocyte Parameters. Clinics in Laboratory Medicine 2015;35:133-63. [DOI: 10.1016/j.cll.2014.10.004] [Cited by in Crossref: 60] [Cited by in F6Publishing: 52] [Article Influence: 8.6] [Reference Citation Analysis]
57 Miwa N, Akiba T, Kimata N, Hamaguchi Y, Arakawa Y, Tamura T, Nitta K, Tsuchiya K. Usefulness of measuring reticulocyte hemoglobin equivalent in the management of haemodialysis patients with iron deficiency. International Journal of Laboratory Hematology 2010;32:248-55. [DOI: 10.1111/j.1751-553x.2009.01179.x] [Cited by in Crossref: 32] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
58 Ogawa C, Tsuchiya K, Tomosugi N, Maeda K. A Hypoxia-Inducible Factor Stabilizer Improves Hematopoiesis and Iron Metabolism Early after Administration to Treat Anemia in Hemodialysis Patients. Int J Mol Sci 2020;21:E7153. [PMID: 32998272 DOI: 10.3390/ijms21197153] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
59 Warady BA, Zobrist RH, Wu J, Finan E; Ferrlecit Pediatric Study Group. Sodium ferric gluconate complex therapy in anemic children on hemodialysis. Pediatr Nephrol 2005;20:1320-7. [PMID: 15971073 DOI: 10.1007/s00467-005-1904-y] [Cited by in Crossref: 41] [Cited by in F6Publishing: 28] [Article Influence: 2.4] [Reference Citation Analysis]
60 Piva E, Brugnara C, Chiandetti L, Plebani M. Automated reticulocyte counting: state of the art and clinical applications in the evaluation of erythropoiesis. Clin Chem Lab Med 2010;48:1369-80. [PMID: 20666695 DOI: 10.1515/CCLM.2010.292] [Cited by in Crossref: 48] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
61 Brugnara C. Reticulocyte cellular indices: a new approach in the diagnosis of anemias and monitoring of erythropoietic function. Crit Rev Clin Lab Sci. 2000;37:93-130. [PMID: 10811141 DOI: 10.1080/10408360091174196] [Cited by in Crossref: 108] [Cited by in F6Publishing: 90] [Article Influence: 4.9] [Reference Citation Analysis]
62 Ramanathan G, Olynyk JK, Ferrari P. Diagnosing and preventing iron overload. Hemodial Int 2017;21 Suppl 1:S58-67. [PMID: 28328144 DOI: 10.1111/hdi.12555] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.2] [Reference Citation Analysis]
63 El-khatib M, Duncan HJ, Kant KS. Role of C-reactive protein, reticulocyte haemoglobin content and inflammatory markers in iron and erythropoietin administration in dialysis patients. Nephrology 2006;11:400-4. [DOI: 10.1111/j.1440-1797.2006.00676.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
64 Yorgin PD, Al-uzri A. Management of renal anemia. In: Warady BA, Schaefer FS, Fine RN, Alexander SR, editors. Pediatric Dialysis. Dordrecht: Springer Netherlands; 2004. pp. 295-331. [DOI: 10.1007/978-94-007-1031-3_19] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
65 Hörl WH. Iron therapy for renal anemia: how much needed, how much harmful? Pediatr Nephrol 2007;22:480-9. [PMID: 17206511 DOI: 10.1007/s00467-006-0405-y] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 1.7] [Reference Citation Analysis]
66 Thomas C, Thomas L. Biochemical Markers and Hematologic Indices in the Diagnosis of Functional Iron Deficiency. Clinical Chemistry 2002;48:1066-76. [DOI: 10.1093/clinchem/48.7.1066] [Cited by in Crossref: 309] [Cited by in F6Publishing: 169] [Article Influence: 15.5] [Reference Citation Analysis]
67 Kaneko Y, Miyazaki S, Hirasawa Y, Gejyo F, Suzuki M. Transferrin saturation versus reticulocyte hemoglobin content for iron deficiency in Japanese hemodialysis patients. Kidney International 2003;63:1086-93. [DOI: 10.1046/j.1523-1755.2003.00826.x] [Cited by in Crossref: 33] [Cited by in F6Publishing: 22] [Article Influence: 1.7] [Reference Citation Analysis]
68 Fishbane S, Shapiro W, Dutka P, Valenzuela OF, Faubert J. A randomized trial of iron deficiency testing strategies in hemodialysis patients. Kidney Int 2001;60:2406-11. [PMID: 11737617 DOI: 10.1046/j.1523-1755.2001.00077.x] [Cited by in Crossref: 124] [Cited by in F6Publishing: 93] [Article Influence: 6.2] [Reference Citation Analysis]
69 Ceylan C, Miskioğlu M, Colak H, Kiliççioğlu B, Ozdemir E. Evaluation of reticulocyte parameters in iron deficiency, vitamin B(12) deficiency and beta-thalassemia minor patients. Int J Lab Hematol 2007;29:327-34. [PMID: 17824912 DOI: 10.1111/j.1365-2257.2006.00872.x] [Cited by in Crossref: 22] [Cited by in F6Publishing: 16] [Article Influence: 1.5] [Reference Citation Analysis]
70 Besarab A, Frinak S, Yee J. An Indistinct Balance: The Safety and Efficacy of Parenteral Iron Therapy. JASN 1999;10:2029-43. [DOI: 10.1681/asn.v1092029] [Cited by in Crossref: 40] [Cited by in F6Publishing: 18] [Article Influence: 1.7] [Reference Citation Analysis]
71 Kim JM, Ihm CH, Kim HJ. Evaluation of reticulocyte haemoglobin content as marker of iron deficiency and predictor of response to intravenous iron in haemodialysis patients. Int J Lab Hematol 2008;30:46-52. [PMID: 18190467 DOI: 10.1111/j.1751-553X.2007.00901.x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 6] [Article Influence: 0.1] [Reference Citation Analysis]
72 Skikne B, Hershko C. Iron Deficiency. In: Anderson GJ, Mclaren GD, editors. Iron Physiology and Pathophysiology in Humans. Totowa: Humana Press; 2012. pp. 251-82. [DOI: 10.1007/978-1-60327-485-2_13] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
73 Katodritou E, Verrou E, Zervas K. Intravenous iron: a useful therapeutic tool but not a panacea. Am J Hematol 2008;83:521-3. [PMID: 18506701 DOI: 10.1002/ajh.21189] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
74 Kotisaari S, Romppanen J, Penttilä I, Punnonen K. The Advia 120 red blood cell and reticulocyte indices are useful in diagnosis of iron-deficiency anemia: Red blood cell indices and the Advia 120 analyzer. European Journal of Haematology 2002;68:150-6. [DOI: 10.1034/j.1600-0609.2002.01532.x] [Cited by in Crossref: 49] [Cited by in F6Publishing: 44] [Article Influence: 2.5] [Reference Citation Analysis]
75 Goodnough LT, Skikne B, Brugnara C. Erythropoietin, iron, and erythropoiesis. Blood 2000;96:823-33. [DOI: 10.1182/blood.v96.3.823.015k49_823_833] [Cited by in Crossref: 3] [Article Influence: 0.1] [Reference Citation Analysis]
76 Baart A, Balvers MG, Hopman MT, Eijsvogels TM, Klein Gunnewiek JM, van Kampen CA. Reticulocyte hemoglobin content in a large sample of the general Dutch population and its relation to conventional iron status parameters. Clinica Chimica Acta 2018;483:20-4. [DOI: 10.1016/j.cca.2018.04.018] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
77 Kee YK, Jeon HJ, Oh J, Shin DH. Hypochromic red cells as predictors of anemia in patients undergoing hemodialysis: an observational retrospective study. Sci Rep 2021;11:24215. [PMID: 34931015 DOI: 10.1038/s41598-021-03746-2] [Reference Citation Analysis]
78 Nalado AM, Mahlangu JN, Duarte R, Paget G, Olorunfemi G, Jacobson BF, Naicker S. Utility of reticulocyte haemoglobin content and percentage hypochromic red cells as markers of iron deficiency anaemia among black CKD patients in South Africa. PLoS One 2018;13:e0204899. [PMID: 30281654 DOI: 10.1371/journal.pone.0204899] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
79 Chuengsaman P, Narenpitak S, Sritippayawan S. Efficacy and safety of recombinant human erythropoietin (Hema-Plus®) for management of anemia in Thai patients on peritoneal dialysis. World J Nephrol 2021; 10(6): 109-121 [PMID: 34909408 DOI: 10.5527/wjn.v10.i6.109] [Reference Citation Analysis]
80 Fishbane S. Anemia in chronic kidney disease: status of new therapies: . Current Opinion in Nephrology and Hypertension 2009;18:112-5. [DOI: 10.1097/mnh.0b013e328324b672] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
81 Kuji T, Toya Y, Fujikawa T, Kakimoto-Shino M, Nishihara M, Shibata K, Tamura K, Hirawa N, Satta H, Kawata S, Kouguchi N, Umemura S. Acceleration of iron utilization after intravenous iron administration during activated erythropoiesis in hemodialysis patients: a randomized study. Ther Apher Dial 2015;19:131-7. [PMID: 25257861 DOI: 10.1111/1744-9987.12237] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
82 Barth RH. Iron Metabolism in End‐Stage Renal Disease. Seminars in Dialysis 2002;12:224-30. [DOI: 10.1046/j.1525-139x.1999.99025.x] [Cited by in Crossref: 5] [Article Influence: 0.3] [Reference Citation Analysis]
83 Sandberg S, Rustad P, Johannesen B, Stølsnes B. Within-subject biological variation of reticulocytes and reticulocyte-derived parameters. European Journal of Haematology 1998;61:42-8. [DOI: 10.1111/j.1600-0609.1998.tb01059.x] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 1.7] [Reference Citation Analysis]
84 Vicinanza P, Catalano L, Pollio G, Vicinanza M, Di Chiara P, Buonanno M, De Renzo A, Rotoli B. Delta-CHr improves the identification of anemic syndromes and the evaluation of hemoglobin synthesis. Clin Lab Haematol 2005;27:217-20. [PMID: 16048487 DOI: 10.1111/j.1365-2257.2005.00696.x] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
85 Birgegård G. Managing anemia in lymphoma and multiple myeloma. Ther Clin Risk Manag 2008;4:527-39. [PMID: 18728848 DOI: 10.2147/tcrm.s1351] [Cited by in Crossref: 12] [Cited by in F6Publishing: 4] [Article Influence: 1.1] [Reference Citation Analysis]
86 Katodritou E, Zervas K, Terpos E, Brugnara C. Use of erythropoiesis stimulating agents and intravenous iron for cancer and treatment-related anaemia: the need for predictors and indicators of effectiveness has not abated. Br J Haematol 2008;142:3-10. [DOI: 10.1111/j.1365-2141.2008.07163.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.7] [Reference Citation Analysis]
87 Bovy C, Tsobo C, Crapanzano L, Rorive G, Beguin Y, Albert A, Paulus J. Factors determining the percentage of hypochromic red blood cells in hemodialysis patients. Kidney International 1999;56:1113-9. [DOI: 10.1046/j.1523-1755.1999.00627.x] [Cited by in Crossref: 44] [Cited by in F6Publishing: 32] [Article Influence: 1.9] [Reference Citation Analysis]
88 Auerbach M, Staffa SJ, Brugnara C. Using Reticulocyte Hemoglobin Equivalent as a Marker for Iron Deficiency and Responsiveness to Iron Therapy. Mayo Clin Proc 2021;96:1510-9. [PMID: 33952394 DOI: 10.1016/j.mayocp.2020.10.042] [Reference Citation Analysis]
89 Alageeli AA, Alqahtany FS, Algahtani FH. The Role of Reticulocyte Hemoglobin Content for the Diagnosis of Functional Iron Deficiency in Hemodialyzed patients. Saudi J Biol Sci 2021;28:50-4. [PMID: 33424282 DOI: 10.1016/j.sjbs.2020.08.030] [Reference Citation Analysis]
90 Jayaranee S, Sthaneshwar P. ORIGINAL ARTICLE: RET-Y and RBC-Y in the diagnosis of iron deficiency associated with anaemia of inflammation: DIAGNOSIS OF IRON-DEFICIENCY ASSOCIATION. International Journal of Laboratory Hematology 2010;32:512-8. [DOI: 10.1111/j.1751-553x.2009.01215.x] [Cited by in Crossref: 4] [Article Influence: 0.3] [Reference Citation Analysis]
91 Warady BA, Kausz A, Lerner G, Brewer ED, Chadha V, Brugnara C, Dahl NV, Watkins SL. Iron therapy in the pediatric hemodialysis population. Pediatr Nephrol 2004;19:655-61. [PMID: 15064942 DOI: 10.1007/s00467-004-1457-5] [Cited by in Crossref: 43] [Cited by in F6Publishing: 33] [Article Influence: 2.4] [Reference Citation Analysis]
92 Eguchi A, Mochizuki T, Tsukada M, Kataoka K, Hamaguchi Y, Oguni S, Nitta K, Tsuchiya K. Serum hepcidin levels and reticulocyte hemoglobin concentrations as indicators of the iron status of peritoneal dialysis patients. Int J Nephrol 2012;2012:239476. [PMID: 23193472 DOI: 10.1155/2012/239476] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
93 Agarwal R, Davis JL, Smith L. Serum albumin is strongly associated with erythropoietin sensitivity in hemodialysis patients. Clin J Am Soc Nephrol 2008;3:98-104. [PMID: 18045859 DOI: 10.2215/CJN.03330807] [Cited by in Crossref: 42] [Cited by in F6Publishing: 18] [Article Influence: 2.8] [Reference Citation Analysis]
94 Davis BH. Diagnostic advances in defining erythropoietic abnormalities and red blood cell diseases. Seminars in Hematology 2001;38:148-59. [DOI: 10.1016/s0037-1963(01)90048-4] [Cited by in Crossref: 4] [Article Influence: 0.2] [Reference Citation Analysis]
95 Besarab A. Parenteral Iron Therapy: Safety and Efficacy. Seminars in Dialysis 2002;12:237-42. [DOI: 10.1046/j.1525-139x.1999.99028.x] [Cited by in Crossref: 4] [Article Influence: 0.2] [Reference Citation Analysis]
96 Karlsson T. Comparative evaluation of the reticulocyte hemoglobin content assay when screening for iron deficiency in elderly anemic patients. Anemia 2011;2011:925907. [PMID: 21808729 DOI: 10.1155/2011/925907] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 1.6] [Reference Citation Analysis]
97 Brugnara C. Use of reticulocyte cellular indices in the diagnosis and treatment of hematological disorders. Int J Clin Lab Res 1998;28:1-11. [DOI: 10.1007/s005990050011] [Cited by in Crossref: 72] [Cited by in F6Publishing: 56] [Article Influence: 3.0] [Reference Citation Analysis]
98 Urrechaga E, Borque L, Escanero JF. Erythrocyte and Reticulocyte Indices on the LH 750 as Potential Markers of Functional Iron Deficiency. Anemia 2010;2010:625919. [PMID: 21490909 DOI: 10.1155/2010/625919] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
99 Yamamoto H, Nishi S, Tomo T, Masakane I, Saito K, Nangaku M, Hattori M, Suzuki T, Morita S, Ashida A, Ito Y, Kuragano T, Komatsu Y, Sakai K, Tsubakihara Y, Tsuruya K, Hayashi T, Hirakata H, Honda H. 2015 Japanese Society for Dialysis Therapy: Guidelines for Renal Anemia in Chronic Kidney Disease. Ren Replace Ther 2017;3. [DOI: 10.1186/s41100-017-0114-y] [Cited by in Crossref: 81] [Cited by in F6Publishing: 20] [Article Influence: 16.2] [Reference Citation Analysis]
100 Ageeli AA, Algahtani FH, Alsaeed AH. Reticulocyte Hemoglobin Content and Iron Deficiency: A Retrospective Study in Adults. Genetic Testing and Molecular Biomarkers 2013;17:278-83. [DOI: 10.1089/gtmb.2012.0337] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
101 Besarab A, Hörl WH, Silverberg D. Iron Metabolism, Iron Deficiency, Thrombocytosis, and the Cardiorenal Anemia Syndrome. The Oncol 2009;14:22-33. [DOI: 10.1634/theoncologist.2009-s1-22] [Cited by in Crossref: 41] [Cited by in F6Publishing: 13] [Article Influence: 3.2] [Reference Citation Analysis]
102 Gasche C, Lomer MC, Cavill I, Weiss G. Iron, anaemia, and inflammatory bowel diseases. Gut. 2004;53:1190-1197. [PMID: 15247190 DOI: 10.1136/gut.2003.035758] [Cited by in Crossref: 293] [Cited by in F6Publishing: 269] [Article Influence: 16.3] [Reference Citation Analysis]
103 Goodnough LT, Skikne B, Brugnara C. Erythropoietin, iron, and erythropoiesis. Blood 2000;96:823-33. [DOI: 10.1182/blood.v96.3.823] [Cited by in Crossref: 235] [Article Influence: 10.7] [Reference Citation Analysis]
104 Bagna R, Spada E, Mazzone R, Saracco P, Boetti T, Cester EA, Bertino E, Coscia A. Efficacy of Supplementation with Iron Sulfate Compared to Iron Bisglycinate Chelate in Preterm Infants. Curr Pediatr Rev 2018;14:123-9. [PMID: 29366419 DOI: 10.2174/1573396314666180124101059] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.8] [Reference Citation Analysis]
105 Hedenus M, Birgegård G. The role of iron supplementation during epoietin treatment for cancer-related anemia. Med Oncol 2009;26:105-15. [DOI: 10.1007/s12032-008-9072-0] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
106 Jabs K, Harmon WE. Anemia and Its Treatment in Children on CAPD/CCPD. In: Fine RN, Alexander SR, Warady BA, editors. CAPD/CCPD in Children. Boston: Springer US; 1998. pp. 183-97. [DOI: 10.1007/978-1-4615-4931-4_12] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
107 Katodritou E, Terpos E, Zervas K, Speletas M, Kapetanos D, Kartsios C, Verrou E, Banti A, Effraimidou S, Christakis J. Hypochromic erythrocytes (%): a reliable marker for recognizing iron-restricted erythropoiesis and predicting response to erythropoietin in anemic patients with myeloma and lymphoma. Ann Hematol 2007;86:369-76. [PMID: 17375302 DOI: 10.1007/s00277-007-0258-x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 1.3] [Reference Citation Analysis]
108 Hudson JQ, Comstock TJ. Considerations for optimal iron use for anemia due to chronic kidney disease. Clin Ther 2001;23:1637-71. [PMID: 11726002 DOI: 10.1016/s0149-2918(01)80135-1] [Cited by in Crossref: 23] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
109 Sudmann-day ÅA, Piehler A, Klingenberg O, Urdal P. Six-day stability of erythrocyte and reticulocyte parameters in-vitro : A comparison of blood samples from healthy, iron-deficient, and thalassemic individuals. Scandinavian Journal of Clinical and Laboratory Investigation 2015;75:247-53. [DOI: 10.3109/00365513.2014.1000370] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
110 Sudmann ÅA, Piehler A, Urdal P. Reticulocyte hemoglobin equivalent to detect thalassemia and thalassemic hemoglobin variants. Int J Lab Hematol 2012;34:605-13. [PMID: 22765164 DOI: 10.1111/j.1751-553X.2012.01442.x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
111 Mittman N, Sreedhara R, Mushnick R, Chattopadhyay J, Zelmanovic D, Vaseghi M, Avram MM. Reticulocyte hemoglobin content predicts functional iron deficiency in hemodialysis patients receiving rHuEPO. Am J Kidney Dis 1997;30:912-22. [PMID: 9398141 DOI: 10.1016/s0272-6386(97)90104-9] [Cited by in Crossref: 108] [Cited by in F6Publishing: 14] [Article Influence: 4.3] [Reference Citation Analysis]
112 Guo W, Bachman E, Li M, Roy CN, Blusztajn J, Wong S, Chan SY, Serra C, Jasuja R, Travison TG, Muckenthaler MU, Nemeth E, Bhasin S. Testosterone administration inhibits hepcidin transcription and is associated with increased iron incorporation into red blood cells. Aging Cell 2013;12:280-91. [PMID: 23399021 DOI: 10.1111/acel.12052] [Cited by in Crossref: 104] [Cited by in F6Publishing: 93] [Article Influence: 11.6] [Reference Citation Analysis]
113 Urrechaga E, Borque L, Escanero JF. Analysis of reticulocyte parameters on the Sysmex XE 5000 and LH 750 analyzers in the diagnosis of inefficient erythropoiesis: RSF IN DIAGNOSIS OF RESTRICTED ERYTHROPOIESIS. International Journal of Laboratory Hematology 2011;33:37-44. [DOI: 10.1111/j.1751-553x.2010.01238.x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
114 Singh A, Coyne D, Shapiro W, Rizkala A, the Drive Study Group. Predictors of the response to treatment in anemic hemodialysis patients with high serum ferritin and low transferrin saturation. Kidney International 2007;71:1163-71. [DOI: 10.1038/sj.ki.5002223] [Cited by in Crossref: 67] [Cited by in F6Publishing: 51] [Article Influence: 4.5] [Reference Citation Analysis]
115 Zumbrennen-Bullough K, Babitt JL. The iron cycle in chronic kidney disease (CKD): from genetics and experimental models to CKD patients. Nephrol Dial Transplant 2014;29:263-73. [PMID: 24235084 DOI: 10.1093/ndt/gft443] [Cited by in Crossref: 48] [Cited by in F6Publishing: 44] [Article Influence: 5.3] [Reference Citation Analysis]
116 Ermens AA, Hoffmann JJ, Krockenberger M, Van Wijk EM. New erythrocyte and reticulocyte parameters on CELL-DYN Sapphire: analytical and preanalytical aspects. Int J Lab Hematol 2012;34:274-82. [PMID: 22151199 DOI: 10.1111/j.1751-553X.2011.01391.x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
117 Mateos González M, de la Cruz Bértolo J, López Laso E, Valdés Sánchez M, Nogales Espert A. Contenido de hemoglobina reticulocitaria para el diagnóstico de la ferropenia. Anales de Pediatría 2009;71:103-9. [DOI: 10.1016/j.anpedi.2009.04.006] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
118 Henry DH, Dahl NV. Iron or vitamin B12 deficiency in anemic cancer patients prior to erythropoiesis-stimulating agent therapy. Community Oncology 2007;4:95-101. [DOI: 10.1016/s1548-5315(11)70057-2] [Cited by in Crossref: 12] [Article Influence: 0.8] [Reference Citation Analysis]
119 Maconi M, Cavalca L, Danise P, Cardarelli F, Brini M. Erythrocyte and reticulocyte indices in iron deficiency in chronic kidney disease: comparison of two methods. Scandinavian Journal of Clinical and Laboratory Investigation 2009;69:365-70. [DOI: 10.1080/00365510802657673] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 1.7] [Reference Citation Analysis]
120 Wheeler S. Assessment and interpretation of micronutrient status during pregnancy. Proc Nutr Soc 2008;67:437-50. [PMID: 18847521 DOI: 10.1017/S0029665108008732] [Cited by in Crossref: 20] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
121 Hörl WH. Clinical aspects of iron use in the anemia of kidney disease. J Am Soc Nephrol 2007;18:382-93. [PMID: 17229908 DOI: 10.1681/ASN.2006080856] [Cited by in Crossref: 95] [Cited by in F6Publishing: 35] [Article Influence: 6.3] [Reference Citation Analysis]
122 Gaweda AE, Goldsmith LJ, Brier ME, Aronoff GR. Iron, inflammation, dialysis adequacy, nutritional status, and hyperparathyroidism modify erythropoietic response. Clin J Am Soc Nephrol 2010;5:576-81. [PMID: 20110344 DOI: 10.2215/CJN.04710709] [Cited by in Crossref: 40] [Cited by in F6Publishing: 16] [Article Influence: 3.3] [Reference Citation Analysis]
123 Glaspy J. Disorders of Blood Cell Production in Clinical Oncology. Abeloff's Clinical Oncology. Elsevier; 2008. pp. 677-92. [DOI: 10.1016/b978-0-443-06694-8.50049-x] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
124 Urrechaga E, Hoffmann JJML. Assessment of iron-restricted erythropoiesis in chronic renal disease: evaluation of Abbott CELL-DYN Sapphire mean reticulocyte hemoglobin content (MCHr). Scandinavian Journal of Clinical and Laboratory Investigation 2019;79:363-7. [DOI: 10.1080/00365513.2019.1622149] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]